• Return to Headlines

Shares of KPTI Down 39.0% Since Downtrend Call on Shares

By Amy Schwartz

SmarTrend identified a Downtrend for Karyopharm Thera (NASDAQ:KPTI) on January 29th, 2019 at $8.41. In approximately 2 month, Karyopharm Thera has returned 39.00% as of today's recent price of $5.13.

In the past 52 weeks, shares of Karyopharm Thera have traded between a low of $3.92 and a high of $21.71 and are now at $5.13, which is 31% above that low price. Over the past week, the 200-day moving average (MA) has gone down 2% while the 50-day MA has declined 4.8%.

Karyopharm Therapeutics, Inc. provides biopharmaceutical products and services. The Company develops and discovers drugs for the treatment of cancer, inflammation, and diseases related to cell proliferation through activity modulation of critical pathways. Karyopham Therapeutics serves the healthcare industry throughout the United States and Germany.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any changes in momentum for shares of Karyopharm Thera.

Log in and add Karyopharm Thera (KPTI) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights karyopharm thera

Ticker(s): KPTI